Carl LeBel - Frequency Therapeutics Chief Officer

Insider

Carl LeBel is Chief Officer of Frequency Therapeutics
Age 64
Phone781 315-4600
Webwww.frequencytx.com

Frequency Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.425) % which means that it has lost $0.425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9993) %, meaning that it created substantial loss on money invested by shareholders. Frequency Therapeutics' management efficiency ratios could be used to measure how well Frequency Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Frequency Therapeutics currently holds 42.95 M in liabilities with Debt to Equity (D/E) ratio of 0.47, which is about average as compared to similar companies. Frequency Therapeutics has a current ratio of 6.63, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Frequency Therapeutics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Joseph CiavarellaPortage Biotech
N/A
MD MBAShattuck Labs
66
Lauren WhiteC4 Therapeutics
N/A
Krishna DVMPrelude Therapeutics
59
Robert KramerPortage Biotech
N/A
Shane MBAOlema Pharmaceuticals
51
Brian VarnumArmata Pharmaceuticals
64
Andrew HirschC4 Therapeutics
53
John CastleMonte Rosa Therapeutics
54
Peter KushnerOlema Pharmaceuticals
85
Ioana HoneLineage Cell Therapeutics
N/A
Nancy PecotaAdverum Biotechnologies
64
Andreas BuschAbsci Corp
62
Neelesh MDPrelude Therapeutics
N/A
Laurent ChardonnetPrelude Therapeutics
59
MBA MDScholar Rock Holding
57
Owen WallaceMonte Rosa Therapeutics
55
Duane BAArmata Pharmaceuticals
74
Sarah JDAbsci Corp
45
Peggy ScherlePrelude Therapeutics
63
Ajim CFAMonte Rosa Therapeutics
47
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people. Frequency Therapeutics (FREQ) is traded on NASDAQ Exchange in USA and employs 46 people.

Management Performance

Frequency Therapeutics Leadership Team

Elected by the shareholders, the Frequency Therapeutics' board of directors comprises two types of representatives: Frequency Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Frequency. The board's role is to monitor Frequency Therapeutics' management team and ensure that shareholders' interests are well served. Frequency Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Frequency Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
John LaMattina, Advisor Board
David Lucchino, President, CoFounder
James Abely, Associate Sec
Christopher Loose, CoFounder Officer
Jason Glashow, Sr Affairs
William MD, VP Medicine
Quentin McCubbin, Chief Officer
Wendy Arnold, Chief Officer
Carl LeBel, Chief Officer
Dana MD, Chief Officer

Frequency Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Frequency Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Frequency Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Chevron Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chevron Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chevron Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chevron Corp to buy it.
The correlation of Chevron Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chevron Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chevron Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chevron Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Frequency Stock

If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes